ALB and metabolic dysfunction-associated steatohepatitis: The results of our study show that models combining baseline variables that include albumin, INR, and platelet count were strongly associated with decompensation events and could estimate 30-day risk of adverse liver-related outcomes in patients with cirrhosis due to MASH or viral hepatitis.